Work

Five‐Year Follow‐Up of Patients With Relapsed and Refractory Classic Hodgkin Lymphoma Treated With Low‐Dose Nivolumab (40 mg): A Matched Cohort Study With Standard‐Dose Therapy

Year: 2025

Type: article

Source: Hematological Oncology

DOI: 10.1002/hon.70146

Authors: Liudmila Fedorova, Kirill Lepik, Polina Kotselyabina, Aminat Balaeva, Andrey Chekalov, Elena Kondakova, Ivan Moiseev, Natalia Mikhailova, Alexander Kulagin

Institution: First Pavlov State Medical University of St. Petersburg

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4415082457

FWCI: 0.588

Cites: 20

Cited by: 1

Related to: